Department of Health Policy & Management and Institute for Medical Technology Assessment, Erasmus University Rotterdam, P.O. Box 1738, 3000 DR Rotterdam, The Netherlands.
J Health Econ. 2012 Jan;31(1):158-68. doi: 10.1016/j.jhealeco.2011.09.004. Epub 2011 Oct 1.
Estimates of WTP per QALY can be taken as an indication of the monetary value of health gains, which may carry information regarding the appropriate height of the cost-effectiveness threshold. Given the far-reaching consequences choosing a particular threshold, and thus the potential relevance of WTP per QALY estimates, it is important to address the validity of these estimates. This study addresses this issue. Our findings offer little support to the validity of WTP per QALY estimates obtained in this study. Implications for general WTP per QALY estimates and further research are discussed.
每增加一个质量调整生命年（QALY）的支付意愿（WTP）的估计可以作为衡量健康收益的货币价值的指标，这些价值可能包含有关成本效益阈值适当高度的信息。鉴于选择特定阈值的深远影响，以及因此 WTP 每 QALY 估计的潜在相关性，解决这些估计的有效性问题非常重要。本研究解决了这个问题。我们的研究结果几乎不支持本研究中获得的 WTP 每 QALY 估计的有效性。还讨论了对一般 WTP 每 QALY 估计和进一步研究的影响。
